Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artyact is a multi-ingredient nutraceutical formulation developed by Jointherapeutics, specifically designed to support joint and bone health. The supplement combines structural components of the extracellular matrix, such as glucosamine and chondroitin, with the antioxidant flavonoid quercetin and *Piper nigrum* extract. *Piper nigrum* extract is often included to enhance the bioavailability of other ingredients and provide anti-inflammatory effects. Additionally, the formulation includes vitamins D and K, which play critical roles in calcium homeostasis and bone mineralization. Artyact is positioned as a food supplement for maintaining joint mobility and skeletal integrity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Artyact.